|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | All cause death | Cardiovascular death |
---|
|
A to Z, 2004 | simvastatin | placebo | acute coronary syndrome | early initiation | | negative | | |
|
SEAS, 2008 NCT | ezetimibe+simvastatin | placebo | aortic stenosis | | Low risk of bias | negative | | |
|
Christenson, 1999 | preoperative simvastatin | no treatment | | | | negative | | |
|
Hong, 2005 | simvastatin | control | heart failure | | Risk of bias | negative | | |
SEAS, 2008 NCT | ezetimibe+simvastatin | placebo | aortic stenosis | | Low risk of bias | negative | | |
HPS (diabetic sub group), 2002 | simvastatin | placebo | diabetic patients | | Low risk of bias | suggesting | | |
4S (diabetic sub group), 1999 | simvastatin | placebo | diabetic patients | secondary prevention | Low risk of bias | suggesting | | |
Mondillo, 2003 | simvastatin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
Aronow , 2003 | simvastatin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
MAAS, 1994 | simvastatin | placebo | secondary prevention | | Exploratory | negative | | |
HPS, 2002 | simvastatin | placebo | secondary prevention | | Low risk of bias | conclusive | | |
4S, 1994 | simvastatin | placebo | secondary prevention | | Low risk of bias | conclusive | | |
A to Z, 2004 | simvastatin | placebo | acute coronary syndrome | early initiation | | negative | | |
Node, 2003 | simvastatin | placebo | heart failure | | | negative | | |
CIS, 1997 | simvastatin | placebo | secondary prevention | | Exploratory | negative | | |
4S (elderly subgroup), 1997 | simvastatin | placebo | elderly | elderly | Low risk of bias | suggesting | | |
HPS (elderly subgroup), 2002 | simvastatin | placebo | elderly | elderly | Low risk of bias | suggesting | | |
HPS (post troke sub group), 2004 | simvastatin | placebo | post stroke | cerebral vascular disease | Low risk of bias | suggesting | | |
HPS (diabetic primary prevention sub group), 2003 | simvastatin | placebo | diabetic | type 2 diabetes | Exploratory | - | | |
HPS (women subgroup) , 2002 | Simvastatin | placebo | women | | Exploratory | suggesting | | |
Landmesser, 2005 | simvastatin | ezetimibe | heart failure | | | - | | |
SEARCH, 2010 NCT | simvastatin high dose | simvastatin | secondary prevention | | Low risk of bias | suggesting | | |
|
HPS (diabetic sub group), 2002 | simvastatin | placebo | diabetic patients | | Low risk of bias | suggesting | | |
4S (diabetic sub group), 1999 | simvastatin | placebo | diabetic patients | secondary prevention | Low risk of bias | suggesting | | |
|
Hong, 2005 | simvastatin | control | heart failure | | Risk of bias | negative | | |
Node, 2003 | simvastatin | placebo | heart failure | | | negative | | |
Landmesser, 2005 | simvastatin | ezetimibe | heart failure | | | - | | |
|
HPS (sub group), 2002 | simvastatin | placebo | Peripheral Arterial Disease | | Low risk of bias | - | | |
Mondillo, 2003 | simvastatin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
Aronow , 2003 | simvastatin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
|
4S, 1994 | simvastatin | placebo | secondary prevention | | Low risk of bias | conclusive | | |
|
HPS (post troke sub group), 2004 | simvastatin | placebo | post stroke | cerebral vascular disease | Low risk of bias | suggesting | | |